Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.670
+0.060 (2.30%)
At close: Jun 12, 2026, 4:00 PM EDT
2.770
+0.100 (3.75%)
After-hours: Jun 12, 2026, 7:55 PM EDT
Galectin Therapeutics Employees
Galectin Therapeutics had 9 employees as of December 31, 2025. The number of employees decreased by 6 or -40.00% compared to the previous year.
Employees
9
Change (1Y)
-6
Growth (1Y)
-40.00%
Revenue / Employee
n/a
Profits / Employee
-$2,937,333
Market Cap
175.84M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 9 | -6 | -40.00% |
| Dec 31, 2024 | 15 | 1 | 7.14% |
| Dec 31, 2023 | 14 | 2 | 16.67% |
| Dec 31, 2022 | 12 | 3 | 33.33% |
| Dec 31, 2021 | 9 | 3 | 50.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 164 |
| Tonix Pharmaceuticals Holding | 142 |
| MediWound | 121 |
| Alector | 103 |
| Acumen Pharmaceuticals | 61 |
| OnKure Therapeutics | 45 |
| Milestone Pharmaceuticals | 38 |
| NovaBridge Biosciences | 30 |
GALT News
- 18 days ago - Galectin Therapeutics presents belapectin data at EASL 2026 - TheFly
- 18 days ago - Galectin Therapeutics Presents New EASL 2026 Oral and Poster Analyses Demonstrating Belapectin's Potential to Modify Disease Progression in Advanced MASH Cirrhosis - GlobeNewsWire
- 4 weeks ago - Galectin Therapeutics Reports March 31, 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Galectin Therapeutics Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Galectin Therapeutics Earnings release: Q1 2026 - Filings
- 4 weeks ago - Galectin Therapeutics publishes NAVIGATE Phase 2b trial results - TheFly
- 4 weeks ago - Galectin Therapeutics Announces Publication of NAVIGATE Phase 2b Trial Results for Belapectin in the Journal of Hepatology - GlobeNewsWire
- 6 weeks ago - Galectin Therapeutics, Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire